Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia.
Department of Biostatistics & Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia.
J Vasc Interv Radiol. 2021 May;32(5):692-702. doi: 10.1016/j.jvir.2020.11.024. Epub 2021 Feb 23.
To quantify changes in the management of pediatric patients with isolated splenic injury from 2007 to 2015.
Patients under 18 years old with registered splenic injury in the National Trauma Data Bank (2007-2015) were identified. Splenic injuries were categorized into 5 management types: nonoperative management (NOM), embolization, splenic repair, splenectomy, or a combination therapy. Linear mixed models accounting for confounding variables were used to examine the direct impact of management on length of stay (LOS), intensive care unit (ICU) days, and ventilator days.
Of included patients (n = 24,128), 90.3% (n = 21,789), 5.6% (n = 1,361), and 2.7% (n = 640) had NOM, splenectomy, and embolization, respectively. From 2007 to 2015, the rate of embolization increased from 1.5% to 3.5%, and the rate of splenectomy decreased from 6.9% to 4.4%. Combining injury grades, NOM was associated with the shortest LOS (5.1 days), ICU days (1.9 days), and ventilator days (0.5 day). Moreover, splenectomy was associated with longer LOS (10.1 days), ICU days (4.5 days), and ventilator days (2.1 days) than NOM. The average failure rate of NOM was 1.5% (180 failures/12,378 cases). Average embolization failure was 1.3% (6 failures/456 cases). Splenic artery embolization was associated with lower mortality than splenectomy (OR: 0.10, P <.001). No statistically significant difference was observed in mortality between embolization and NOM (OR: 0.96, P = 1.0).
In pediatric splenic injury, NOM is the most utilized and associated with favorable outcomes, most notably in grades III to V pediatric splenic injury. If intervention is needed, embolization is effective and increasingly utilized most significantly in lower grade injuries.
量化 2007 年至 2015 年期间小儿脾损伤患者治疗管理的变化。
在国家创伤数据库(2007-2015 年)中确定年龄在 18 岁以下且有登记脾损伤的患者。脾损伤分为 5 种管理类型:非手术治疗(NOM)、栓塞、脾修补、脾切除术或联合治疗。使用线性混合模型来校正混杂因素,以检查治疗对住院时间(LOS)、重症监护病房(ICU)天数和呼吸机天数的直接影响。
在纳入的患者中(n=24128),90.3%(n=21789)、5.6%(n=1361)和 2.7%(n=640)分别接受了 NOM、脾切除术和栓塞治疗。从 2007 年到 2015 年,栓塞治疗的比例从 1.5%增加到 3.5%,而脾切除术的比例从 6.9%下降到 4.4%。合并损伤等级后,NOM 与最短 LOS(5.1 天)、ICU 天数(1.9 天)和呼吸机天数(0.5 天)相关。此外,脾切除术与 NOM 相比,LOS(10.1 天)、ICU 天数(4.5 天)和呼吸机天数(2.1 天)更长。NOM 的平均失败率为 1.5%(180 例/12378 例)。平均栓塞失败率为 1.3%(456 例中有 6 例失败)。脾动脉栓塞术与脾切除术相比死亡率更低(OR:0.10,P<.001)。栓塞术与 NOM 之间的死亡率无统计学差异(OR:0.96,P=1.0)。
在小儿脾损伤中,NOM 是最常用的治疗方法,与良好的结果相关,尤其是在 3 级至 5 级小儿脾损伤中。如果需要干预,栓塞术是有效的,且在较低级别的损伤中越来越多地被采用。